TECHNOLOGY DESCRIPTION
Our innovation:
New family of amphiphilic copolymers and terpolymers that form bioactive polymeric nanoparticles
This family of copolymers and terpolymers contain an antioxidant agent as a bioactive and hydrophobic component
This family of copolymers and terpolymers are highly antioxidant and amphiphilic, and form nanoparticles
These nanoparticles can be used as controlled delivery systems for the administration of bioactive agents with low solubility in physiological conditions (e.g. active substances with analgesic, anti-inflammatory, activating tissue regeneration, antibiotic, antiproliferative, antimicrobial, etc. effects)
BENEFITS
Competitive advantages: Good stability in physiological medium. Easily eliminated by the body through the normal metabolic pathway. They can be administered by injection in the area that are required or applied in aqueous dispersions or in hydrophilic gels either topically or locally. Good cytocompatibility.
LIMITATIONS
To be determined
APPLICATIONS
Patient need addressed: osteo-articular regeneration, skin diseases
Readiness Level (TRL)
 Patent Grading Report |
Patent Grading ReportThe Grading Patents Report evaluates and grades US patents Sample Buy from Wisdomain |
STATUS
Current status
Spanish patent application P201830594, International patent PCT to be applied
AVAILABILITY
Available for
Licensing or Assignment
INVENTOR / TEAM
Julio San Roman, Maria Rosa Aguilar, Raquel Palao, Alberto Nakal
